Schedule 13G ownership disclosure

Ohr Pharmaceutical Inc

Security class unavailable

Event date: 2020-12-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.7960%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535384-20-000004
Form type
SC 13G/A
Filer
Kershner Trading Americas,LLC
CIK
CIK 1535384
Filed
Dec 29, 2020
Reporting period
Dec 04, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub